An Investigator-Sponsored, Open-Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LB1148 for Subjects Undergoing Elective Bowel Resection

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 22 Mar 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

16 Mar 2022 According to a Palisade Bio media release, Stonegate Capital Partners will host a conference call to discuss the data.
16 Mar 2022 According to a Palisade Bio media release, 3/11 subjects underwent a second surgery.
16 Mar 2022 According to a Palisade Bio media release, pooled-analysis results from studies LBS-IST-POI-101 and LBS-POI-201-CN (PROFILE-CN) are featured today at the Next Big Thing session of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2022 Annual Meeting 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com